Pritam Biswas

Post Doctoral Fellow

UAMS

Postdoc Researcher

15 h-index 85 pubs 745 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Pritam Biswas's research focuses on the molecular mechanisms underlying cellular apoptosis, particularly in the context of cancer, and the potential of nanomaterials in therapeutic applications. His work investigates the role of specific lipid mediators and cytokines, such as IL-13 and 13(S)HpODE, in initiating apoptotic pathways through signaling cascades involving MAO-A, ROS, and p53/p21. Biswas also explores the application of redox nanomedicine for conditions like chronic kidney disease, aiming to recondition mitochondria. His research has involved preclinical animal studies to assess the safety and efficacy of nanomaterials, including their redox buffering capacity in relation to ROS-based therapeutics and toxicity. He has co-authored publications with researchers at the University of Arkansas for Medical Sciences, including Samrat Roy Choudhury and Akhilesh Kaushal. Biswas has an h-index of 15 and has authored 85 publications with 745 citations.

Metrics

h-index: 15
Publications: 85
Citations: 745

Selected Publications

Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia (2025)

Genes & Diseases 1 citation DOI OpenAlex
Abstract 2281 Epigenetic Drivers and Subtype-Specific Roles of DNMT3B in Acute Myeloid Leukemia (2025)

Journal of Biological Chemistry 1 citation DOI OpenAlex
Abstract P16: CBFA2T3-GLIS2 fusion leads to a distinct DNA methylation enhancer landscape in pediatric acute myeloid leukemia (2024)

Blood Cancer Discovery 1 citation DOI OpenAlex